Ignite Creation Date:
2024-05-06 @ 12:14 PM
Last Modification Date:
2024-10-26 @ 12:56 PM
Study NCT ID:
NCT03705403
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-17
First Post:
2018-06-27
Brief Title:
IMMUNOtherapy and Stereotactic ABlative Radiotherapy IMMUNOSABR a Phase II Study
Sponsor:
Maastricht University Medical Center
Organization:
Maastricht University Medical Center
Organization Data
Organization:
Maastricht University Medical Center
Class:
OTHER
Study ID:
UM2018IMMUNOSABR2RLPL
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Maastricht University Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Institut du Cancer de Montpellier - Val dAurelle | OTHER |
| Academisch Ziekenhuis Maastricht | OTHER |
| The Netherlands Cancer Institute | OTHER |
| University Medical Center Nijmegen | OTHER |
| Erasmus Medical Center | OTHER |
| University Ghent | OTHER |
| KU Leuven | OTHER |
| Centre Oscar Lambret | OTHER |
| Gasthuis Zusters Antwerpen | OTHER |
| University College London | OTHER |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | OTHER |
| University Hospital Dresden | OTHER |
| University Hospital Tuebingen | OTHER |
| Heidelberg University | OTHER |
| Catholic University of the Sacred Heart | OTHER |